Chronic pain is rising while lifespan extension stalls, suggesting a missing link between nociception and longevity pathways. Acute activation of TRPV1, a nociceptor ion channel, triggers calcium influx that activates CAMKK2‑AMPK signaling, a known driver of autophagy and mitochondrial remodeling. In the intestinal epithelium, sub‑threshold TRPV1 activity can modulate Wnt/β‑catenin signaling by altering prostaglandin E2 levels, thereby influencing stem cell proliferation without triggering inflammation. We hypothesize that physiological pain signals act as a hormetic cue that sustains intestinal stem cell (ISC) niche fitness and systemic metabolic flexibility, and that their pharmacological bluntness accelerates age‑related tissue decline.

Mechanistically, we propose three linked steps. First, intermittent TRPV1 activation raises intracellular Ca2+ to a level that stimulates CAMKK2, which phosphorylates AMPK. AMPK activation suppresses mTORC1, initiating autophagy and improving proteostasis. Second, AMPK‑dependent phosphorylation of β‑catenin reduces its nuclear translocation, fine‑tuning Wnt target gene expression to maintain a balanced ISC pool—enough for renewal but not excess that drives neoplasia. Third, TRPV1‑derived CGRP release acts locally on enteroendocrine cells to release peptide YY, which improves glucose tolerance and reduces systemic inflammation. Together, these cascades create a feedback loop where low‑grade nociceptive tone preserves tissue repair capacity.

This hypothesis yields several testable predictions. (1) Feeding wild‑type mice a low‑dose capsaicin regimen (0.01% w/w) from middle age will increase autophagic flux (LC3‑II/I ratio) and crypt Wnt target gene expression relative to vehicle controls, an effect absent in TRPV1‑knockout littermates. (2) Humans undergoing long‑term NSAID or opioid therapy will show reduced LC3‑II accumulation and lower nuclear β‑catenin in colonic biopsies compared with age‑matched non‑users, even after adjusting for pain severity. (3) In Drosophila, genetic knockdown of the TRPV1 homolog (painless) in enteric neurons will accelerate age‑dependent ISC loss measured by Prospero‑positive cell counts and shorten median lifespan, whereas neuronal overexpression of painless will extend lifespan only when autophagy genes are intact. Conversely, if analgesic use does not correlate with diminished autophagy markers or altered Wnt signaling in human tissue, or if capsaicin supplementation fails to improve ISC metrics in TRPV1‑deficient animals, the hypothesis would be falsified.

It's clear that aging degrades peripheral nociceptor function and spinal inhibition {1} and that central sensitization amplifies pain signals in maladaptive ways {2}. Yet these same pathways, when engaged at low intensity, intersect with evolutionarily conserved stress‑response networks. By reframing pain as a potential longevity signal rather than merely a symptom to erase, we redirect analgesic development toward preserving, not abolishing, physiologic nociceptive tone.